Venrock

When scaling your workload is a matter of saving lives | 4/20/2020

On March 16, 2020, at 9:26 PM, I received an urgent email from my friend DJ Patil, former White House Chief Data Scientist, Head of Technology for Devoted Health, a Senior Fellow at the Belfer Center at the Harvard Kennedy School, and Advisor to Venrock Partners. You don’t get that many titles after your name unless you’re pretty good at something. For DJ, that “something” is math and computer science …

RDMD raises $14M for rare disease real-world evidence generation - MedCity News | 4/17/2020

… Amount raised: $100 million The company said Thursday that it had raised the money in an equity financing round led by PSP Investments, a Canadian pension investment manager. Existing investors KCK Group, Sofinnova Partners, Venrock , T. Rowe Price, TPG’s The Rise Fund, Pfizer Ventures and Johnson & Johnson Innovation, JJDC Inc. also participated. RefleXion, which is a therapeutic oncology company focused on biology-guided radiotherapy, or BgRT, will be used to …

Follow Venrock:    

COVID-19 is normalizing telehealth, and that’s a good thing | 4/16/2020

By Bob Kocher MD 5 minute Read Bob Kocher is a physician, a partner at venture capital firm Venrock , and a senior fellow at the USC Schaeffer Center. He was recently chosen by California Governor Gavin Newsom to serve on the state’s new public-private coronavirus testing task force, which seeks to significantly expand testing capacity across the state. Previously, Kocher served as a special assistant to President Obama and …

RefleXion Raises $100 Million for Cancer Treatment Commercialization | Business Wire | 4/16/2020

… thrilled to support RefleXion during this next phase of their growth as they ramp up market and clinical adoption of this groundbreaking technology.” RefleXion’s existing investors, TPG’s The Rise Fund, KCK Group, Sofinnova Partners, Venrock , T. Rowe Price, and global pharmaceutical leaders, Pfizer Ventures and Johnson & Johnson Innovation, JJDC Inc., all participated in the round. BofA Securities and Morgan Stanley & Co., LLC acted as placement agents for the company. “This …

Keros upsizes IPO, raising $96M for blood and musculoskeletal trials | FierceBiotech | 4/8/2020

… a shot at carving out a space among those competitors. At the start of March, Keros raised a $56 million series C round led by new investors Foresite Capital, OrbiMed, Cowen Healthcare Investments and Venrock . After the series C, Foresite owned 10% of Keros, but entities affiliated with Pontifax Venture Capital remained the big player with a 33% stake. All the key players are set to dilute their stakes through …

SC 13G/A - Venrock Healthcare Capital Partners II, L.P. (0001602264) (Filed by) | 4/3/2020

… No.: 005-91001 Film No.: 20773335 SIC : 2834 Pharmaceutical Preparations Mailing Address 7 BRYANT PARK 23RD FLOOR NEW YORK NY 10018 Business Address 7 BRYANT PARK 23RD FLOOR NEW YORK NY 10018 650 475 3734 Venrock Healthcare Capital Partners II, L.P. (Filed by) CIK : 0001602264 (see all company filings) IRS No. : State of Incorp.: DE Fiscal Year End: 1231 Type: SC 13G/A …

Biotechs startups threatened by coronavirus work from home - Protocol | 3/31/2020

… tech, in your inbox every morning. Sign up for Source Code. Sign Up “In my biotech lifetime, I’ve not seen something of this magnitude. Even 9/11 didn’t cause business disruption in this way,” said Venrock Ventures partner Racquel Bracken, who is also the CEO of seed-stage microbiome biotech Federation Bio, based in South San Francisco. She has 15 employees, all of whom must go into the lab to run …

Biotech innovations to spur next phase of personalized care | Modern Healthcare | 3/28/2020

… body, could offer another way to monitor changes to patient health. There’s been a “first wave” of research focused on microbiome-based therapies so far, said Racquel Bracken, a partner at venture-capital firm Venrock focused on biotechnology and pharmaceuticals, which she expects to advance quickly in the next few years. She pointed to research being done at Stanford University to study the microbiome, with an ultimate goal of developing …

Verastem Oncology Reports Fourth Quarter and Full-Year 2019 Financial Results | 3/27/2020

… Premier Life Science Investors. On March 3, 2020, Verastem Oncology completed a private placement offering of approximately 46.5 million shares of its common stock to certain institutional investors, including RA Capital Management, Vivo Capital, Venrock Healthcare Capital Partners, Farallon Capital Management, Acuta Capital, EcoR1 Capital LLC, Avidity Partners and Logos Capital at a price of $2.15 per share, a 12.6% premium to the February 27, 2020 closing price. The gross …

GigSmart Launches Health Marketplace to Provide Benefits to Independent Workers | PR Newswire | 3/25/2020

… on-demand work marketplaces and employers of independent and part-time workers, including Uber, Postmates, Airbnb, and others. Launched in 2014, Stride is backed by the leading health and consumer venture finance firms, including Venrock , New Enterprise Associates, and F-Prime Capital Partners. MEDIA CONTACT: Rich Oakes [email protected] 720.892.6371 Related Images gigsmart-logo.png GigSmart Logo The logo for GigSmart SOURCE GigSmart Related Links http://www.gigsmart.com …

Starbucks teams with startup to extend mental health perks to U.S. employees | FierceHealthcare | 3/18/2020

… Venture Partners led the funding round and was joined by new investor Meritech Capital Partners as well as existing investors Casdin Capital, Crown Venture Fund, Glynn Capital, Greylock Partners, Providence Ventures, Tenaya Capital and Venrock . The company plans to use the new funds to build out its technology and expand its network of mental health providers. In the U.S., close to 48 million people, or 1 in 5 adults, experienced …

Skyryse Introduces FlightOS, An Automation Flight Operating System That Enables Anyone To Safely Fly Any Aircraft Like An Experienced Pilot | PR Newswire | 3/17/2020

… Skyryse is a transportation technology company built by transportation experts from Airbus, Boeing, Ford, JetBlue, Moog, SpaceX, Tesla, Uber, the U.S. Military and Zoox. The company has raised $38 million from leading investors including Venrock , Eclipse Ventures, Fontinalis, Stanford University and Bill Ford , the executive chairman of Ford Motor Company. SOURCE Skyryse Related Links https://skyryse.com …

FDA Clearance Brings RefleXion Closer to Expanding Cancer Treatment Market | Business Wire | 3/13/2020

… BgRT technology will synchronize these data with the linear accelerator to direct radiotherapy to tumors with subsecond latency. RefleXion is backed by premier investment firms TPG Growth/The Rise Fund, Sofinnova Partners, KCK Group, Venrock , T. Rowe Price and global pharmaceutical leaders Pfizer Venture Investments and Johnson & Johnson Innovation, JJDC Inc. The RefleXion X1 BgRT capability requires 510(k) clearance and is not available for sale. View source version on …

CarAdvise & Stride Partner to Drive More Value in the Gig-Economy and Beyond | PRWeb | 3/13/2020

… Uber, Postmates, DoorDash, GrubHub, Rover, Care.com, TaskRabbit, Keller Williams and more, helping them provide their workers with access to a full suite of health and wealth benefits and perks. The company is backed by Venrock , New Enterprise Associates and F-Prime Capital Partners. Share article on social media or email: View article via …

Avadel Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results | Globe Newswire | 3/12/2020

… is increasingly being recognized by the investment community, as we completed in February 2020 a $65 million private placement priced at-the-market with leading biotech investors, Vivo Capital, Avoro Capital Advisors, RTW Investments, Venrock Healthcare Capital Partners, Acuta Capital, and KVP Capital.” “Looking ahead, we have several near-term clinical milestones, including the last patient last visit for the pivotal Phase 3 REST-ON trial for FT218 scheduled to …

Mental health benefits startup Lyra Health raises $75M - MedCity News | 3/12/2020

… than $175 million to date. Institutional Venture Partners (IVP), a late-stage venture capital firm, led the funding round, with participation from Meritech Capital Partners as well as past investors Casdin Capital, Providence Ventures, Venrock and others. Burlingame, Calif.-based Lyra plans to use the new funds to build out its technology and expand its network of mental health providers. Lyra Health CEO David Ebersman The startup offers its services …

Lyra Health Announces Closing of $75M Series C Financing | 3/11/2020

… investments in rapidly-growing technology companies. IVP was joined by new investor Meritech Capital Partners, as well as existing investors Casdin Capital, Crown Venture Fund, Glynn Capital, Greylock Partners, Providence Ventures, Tenaya Capital, and Venrock . Approximately 20 percent of Americans will suffer from a mental health condition this year, and, too often, our current health care system fails them. Fortunately, employers are increasingly demanding better services for their employees and …

Biopharmaceutical Company Amunix Closes $73 Million In Funding | 3/11/2020

… raised an oversubscribed $73 million Series A financing. Omega Funds led the funding with participation from existing investor Frazier Healthcare Partners and new investors Longitude Capital, Redmile Group, Polaris Partners, Casdin Capital, Two River, Venrock , and Delian Capital. Amunix is focused on advancing a pipeline of novel T cell engagers (XPATs) and cytokines (XPACs) that are selectively activated in the tumor microenvironment and are designed to overcome toxicity and immunogenicity …

Employee behavioral health benefits platform Lyra Health closes $75M Series C | MobiHealthNews | 3/11/2020

… The new investments were headed by IVP, with additional support coming from new backer Meritech Capital Partners and prior investors Casdin Capital, Crown Venture Fund, Glynn Capital, Greylock Partners, Providence Ventures, Tenaya Capital and Venrock . WHAT THEY DO Lyra’s platform primarily serves to match employees and their dependents to mental health care professionals and personalized, evidence-based treatments. Using machine learning, the technology guides users through their encounters and provides …

Mental Health Company Lyra Raises $75 Million Led By IVP | 3/11/2020

… C funding. This round of funding was led by IVP. New investor Meritech Capital Partners as well as existing investors Casdin Capital, Crown Venture Fund, Glynn Capital, Greylock Partners, Providence Ventures, Tenaya Capital, and Venrock joined the round. Around 20% of Americans will suffer from a mental health condition this year. And our current health care system often fails them. Fortunately, employers have been demanding better services for their employees …

Digital Clinical Assistant Company Suki Raises $20 Million | 3/8/2020

… raised $20 million in Series B funding. New investor Flare Capital Partners led the round — which also includes new investors Breyer Capital and Epsilon Health as well as returning investors First Round Capital and Venrock . In connection with the funding round, Flare Capital Partners co-founder and general partner Bill Geary is joining the Suki board of directors. Over the past couple of years, Suki established itself as a leading …

Startups Weekly: Remote-first SaaS products boom as workers stay home – TechCrunch | 3/7/2020

… Connie Loizos caught up with long-time healthcare investor Camille Samuels for TechCrunch . “The reason you hear about cancer and orphan diseases so much is that you can price high in those areas,” the Venrock partner explains. “In therapeutic areas where you can’t price high because there are already a bunch of generics on the market — pain, depression, other huge unmet needs — you don’t see as much innovation. It’s a …

Remote First SaaS products are booming when employees stay at home – TechCrunch | 3/7/2020

… Connie Loizos met longtime health investor Camille Samuels for TechCrunch. “The reason why you hear so much about cancer and orphan diseases is that you can get high prices in these areas,” explains the Venrock partner. “In therapeutic areas where you can’t get high prices because there are already a number of generic drugs on the market – pain, depression, other big, unmet needs – you don’t see as much innovation. It’s …

Medical voice assistant Suki raises $20M - MedCity News | 3/6/2020

… based VC that focuses on healthcare technology, led the funding round. Co-founder and general partner Bill Geary will join Suki’s Board of Directors as part of the deal. Other investors included First Round, Venrock and Breyer Capital. The new funds bring the total amount raised to date by Suki to $40 million. The Redwood City-based startup plans to use the additional funding to build out its user base …

Venture capital and health system investors are bullish on tech startups | Modern Healthcare | 1/18/2020

… be scared off by the Theranos story,” he said. Startups, arguably more so than incumbents, have the potential to introduce new approaches to old problems, said Dr. Bob Kocher, partner at venture-capital firm Venrock and a former special assistant to the president for healthcare and economic policy during the Obama administration. When a startup proves its model is successful, not only do “those companies grow, but also they get …

Digital Health

Venture capital and health system investors are bullish on tech startups | Modern Healthcare | 1/18/2020

… of that,” said Chris Coburn, chief innovation officer at Partners, of the new fund. Partners is in good company, as digital healthcare tech has been a growing area for investment in the past decade. Digital … problems, said Dr. Bob Kocher, partner at venture-capital firm Venrock and a former special assistant to the president for healthcare and economic policy during the Obama administration. When a startup proves its model is …

Center for Devices and Radiological Health

** | 1/12/2020**

… air. “It’s a mixed bag,” he said. Experts such as Dr. Bob Kocher, a partner at the venture capital firm Venrock, are blunter. “Most AI products have little evidence to support them,” Kocher said. Some … said Bakul Patel, director for digital health at the FDA’s Center for Devices and Radiological Health. The FDA has not yet authorized “unlocked” AI devices, whose results could vary from month to month in ways …

Medicare

Healthcare surprises for 2020 from top VC investors - Business Insider | 12/19/2019

… what they think would be the biggest surprises to hit healthcare in 2020. Those surprises could include some form of “Medicare for All” gaining traction, Amazon making a big healthcare deal, or Apple becoming a … venture investors think could rock 2020 was government action. For Venrock partner Bryan Roberts, having the government do something material in healthcare would be the biggest surprise. That could be anything on healthcare costs or …

Virtual Care

CB Insights - Digital Health 150: The Digital Health Startups Redefining The Healthcare Industry | 11/14/2019

… investors among the companies selected. Investor Number of deals F-Prime Capital 31 New Enterprise Associates 30 Google Ventures 29 Venrock 28 Founders Fund 27 Khosla Ventures 27 GE Ventures 22 Social Capital 20 .406 … providing novel services that aim to boost accessibility and convenience. Virtual care clinics such as Maven Clinic are also helping women gain better access to providers that cater specifically to women’s health needs and concerns …

HIPAA

Nightfall AI Gets Funded to Secure Cloud Data – Tehrani.com – Comm & Tech Blog | 11/11/2019

… problem, Nightfall AI (formerly known as Watchtower AI), launched with $20.3 million in funding led by Bain Capital Ventures and Venrock. Pear VC, Sri Viswanath, CTO of Atlassian, and Kelvin Beachum of the New York … with a number of regulatory regimes, including CCPA, GDPR, and HIPAA. Nowadays business-critical data in the enterprise is sprayed across a broad set of disparate cloud systems. This leads to information security problems around …

Biotech

Term Sheet: Nov. 08, 2019 | 11/8/2019

… and Palo Alto, Calif.-based cloud-native data loss prevention platform, raised $20.3 million in funding. Bain Capital Ventures and Venrock led the round, and were joined by investors including Pear VC, Sri Viswanath , and … round. HEALTH & LIFE SCIENCES DEALS - eGenesis , a Cambridge, Mass.-based biotechnology company utilizing gene editing technologies for the development of human-compatible organs, raised $100 million in Series B funding. Fresenius Medical Care Ventures led …

Health Tech

AI voice tech startup Suki partners with Google Cloud | Healthcare Dive | 10/30/2019

… almost two additional hours on paperwork. Providers spend more than half of their workday on EHR and computer tasks. The startup was founded by Soni and is backed by funding from investors like Venrock, First Round and Social Capital. The company recently raised $20 million to advance the technology in a Series A round led by Venrock. It wasn’t an outlier. Robin Healthcare, another voice-enabled clinician workflow tool, raised …

Clinical Data

Cyteir Therapeutics scores $40.2 mln Series B | PE Hub | 10/15/2019

… lethal therapies for cancer, has secured $40.2 million in Series B funding. Novo Holdings led the round with participation from Venrock, DROIA Oncology Ventures, Osage University Partners, Lightstone Ventures and Celgene Corporation . As part of … patients in this trial.” In March 2019, Cyteir presented pre-clinical data at the 2019 American Association for Cancer Research annual meeting that validated the mechanism of action underlying the company’s synthetic lethal platform and …

Medicare Advantage

The mad rush to sell private Medicare plans to seniors | 10/11/2019

The mad rush to sell private Medicare plans to seniors Written By: Bloomberg Oct 10th 2019 - 7pm. Medicare Advantage plans are rushing to sign up customers after new regulations allow them to offer more non … 20 years,” said Bob Kocher, a partner at venture firm Venrock. The firm backed Devoted Health and Kocher served as the company’s chief medical officer for a year. “There should be a lot of pent …

ACA

Leading Gig Platforms put Stride’s New Benefits Platform to Work | PR Newswire | 8/21/2019

… less time looking for their rewards and more time using them.” “The Stride Benefits Platform is an important part of Instacart’s new, more holistic suite of offerings and resources designed to support our shoppers in … and wealth benefits and perks. The company is backed by Venrock, New Enterprise Associates and F-Prime Capital Partners. About DoorDash: Doordash is a technology platform that connects customers with their favorite local and national …

ACO

Misty Robotics Selects Microsoft’s .NET Core for Its Robot Platform and Tools | Business Wire | 5/6/2019

… will offer the robot maker the latest tooling from Microsoft as well as cross-platform compatibility including support of Windows, macOS, and Linux. The open-source, general-purpose development platform maintained by Microsoft and the … Based in Boulder, Colorado, the company is financially backed by Venrock, Foundry Group and others. Contacts …

ACOs

Misty Robotics Selects Microsoft’s .NET Core for Its Robot Platform and Tools | Business Wire | 5/6/2019

… will offer the robot maker the latest tooling from Microsoft as well as cross-platform compatibility including support of Windows, macOS, and Linux. The open-source, general-purpose development platform maintained by Microsoft and the … Based in Boulder, Colorado, the company is financially backed by Venrock, Foundry Group and others. Contacts …

AMA

What social media says about the opioid crisis - POLITICO | 4/5/2019

… buyer: The Committee on Foreign Investment in the United States is forcing a Chinese firm to divest from startup PatientsLikeMe. — Amazon Alexa gets medical skills: The voice assistant is now HIPAA compliant. eHealth Tweet of … data sets and Chinese money are the ones in trouble,” Venrock investor Bob Kocher told Morning eHealth. AMAZON UPSKILLS ALEXA — The retail giant’s voice assistant Alexa has new HIPAA compliant skills allowing customers to give …

CRISPR

Brainstorm Health: Free CRISPR Enzyme, Doug Jones and CHIP, Novartis Generics Unit | Fortune | 12/14/2017

10:34 AM EST Good morning, readers! This is Sy. CRISPR gene editing is widely regarded as one of the most significant advances in the life sciences in decades. The technology, which allows scientists to slice … factions’ various affiliated biotechs). Well, Inscripta, a startup backed by Venrock, wants to take the IP considerations out of the equation by providing a new kind of CRISPR enzyme to (most) scientists at no cost …

Pear Therapeutics

Venture capital and health system investors are bullish on tech startups | Modern Healthcare | 1/18/2020

… incumbents, have the potential to introduce new approaches to old problems, said Dr. Bob Kocher, partner at venture-capital firm Venrock and a former special assistant to the president for healthcare and economic policy during … most investors somewhat uncomfortable,” acknowledged Dr. Corey McCann, CEO of Pear Therapeutics, a developer of prescription digital therapeutics. Pear, which has received FDA clearance for app-based products that help treat substance and opioid use …

Kyruus

Venture capital and health system investors are bullish on tech startups | Modern Healthcare | 1/18/2020

… incumbents, have the potential to introduce new approaches to old problems, said Dr. Bob Kocher, partner at venture-capital firm Venrock and a former special assistant to the president for healthcare and economic policy during … chatbot and telemedicine provider Babylon, online appointment scheduling startups like Kyruus and Zocdoc, and companies like Evariant, recently acquired by Healthgrades , that help with patient acquisition and retention, according to PitchBook. The healthcare industry has …

Illumina

Biopharma’s Big Week Begins: A Glimpse Into the JP Morgan Healthcare Conference | Fortune | 1/14/2020

… acquiring Stimgenics , a company focused on spinal cord stimulation in order to treat chronic pain just ahead of JPM week; Illumina, a titan of the genomics space, reached a partnership with Swiss drug developer Roche … by Bryan Roberts, one of the investing gurus over at Venrock, and John Stuelpnagel, a co-founder of Illumina and Ariosa Diagnostics, as well as the chairman of biotech Inscripta (note: Venrock is an investor …

Sofinnova Partners

Synthetic Lethality-based Drugs & Targets World Market, Forecast to 2030 by Type of Molecules, Different Target Indications, Synlet Targets, Route of Administration, and Key Geographical Regions | Financial Buzz | 1/9/2020

… Ministry of Education Singapore sovereign wealth fund Sloan-Kettering Inst Can Research Sloan-Kettering Institute SMBC Venture Capital Snap Bio Sofinnova Partners SOSV SR One SRI International St George Hospital St. Jude Children’s Research Hospital … Services UT Southwestern Medical Center UTokyo Innovation Platform Vanderbilt University Venrock Versant Ventures Vivo Capital of Palo Alto Voyager Therapeutics Wellcome Sanger Institute Woodford Patient Capital Trust Worldwide Cancer Research WuXi AppTec Ventures WuXi Healthcare …

CVS

The New Age of Primary Care | 1/3/2020

… Inc. that are better known for operating pharmacy counters and managing health plans are now turning into primary care providers. CVS Health Corp. CVS, -0.57% , Humana HUM, +0.90% , Walgreens WBA, -0.34% , Walmart Inc. WMT, -0.66 … said Dr. Bob Kocher, a partner at venture-capital firm Venrock. “There is a belief that the pendulum is swinging to the next-generation version of managed care.” Read: Expect stock volatility for some health …

CVS Health

The New Age of Primary Care | 1/3/2020

… Inc. that are better known for operating pharmacy counters and managing health plans are now turning into primary care providers. CVS Health Corp. CVS, -0.57% , Humana HUM, +0.90% , Walgreens WBA, -0.34% , Walmart Inc. WMT, -0.66 … said Dr. Bob Kocher, a partner at venture-capital firm Venrock. “There is a belief that the pendulum is swinging to the next-generation version of managed care.” Read: Expect stock volatility for some health …

Walmart Health

Health insurers and retail pharmacies are making a play for primary care | MSN | 12/26/2019

… known for operating pharmacy counters and managing health plans are now turning into primary care providers. “ CVS Health, Humana, Walgreens, Walmart and UnitedHealth Group now operate hundreds of clinics that directly market themselves as primary … said Dr. Bob Kocher, a partner at venture-capital firm Venrock. “There is a belief that the pendulum is swinging to the next-generation version of managed care.” : Expect stock volatility for some health care …

Walgreens Healthcare

Health insurers and retail pharmacies are making a play for primary care | MSN | 12/26/2019

… making a play for primary care MarketWatch 1 hr ago Jaimy Lee A handful of companies like Humana Inc. and Walgreens Boots Alliance Inc. that are better known for operating pharmacy counters and managing health … said Dr. Bob Kocher, a partner at venture-capital firm Venrock. “There is a belief that the pendulum is swinging to the next-generation version of managed care.” : Expect stock volatility for some health care …

UnitedHealth Group

Health insurers and retail pharmacies are making a play for primary care | MSN | 12/26/2019

… operating pharmacy counters and managing health plans are now turning into primary care providers. “ CVS Health, Humana, Walgreens, Walmart and UnitedHealth Group now operate hundreds of clinics that directly market themselves as primary care providers … said Dr. Bob Kocher, a partner at venture-capital firm Venrock. “There is a belief that the pendulum is swinging to the next-generation version of managed care.” : Expect stock volatility for some health care …

Apple Health

Healthcare surprises for 2020 from top VC investors - Business Insider | 12/19/2019

… 2020. Those surprises could include some form of “Medicare for All” gaining traction, Amazon making a big healthcare deal, or Apple becoming a medical provider, they said. Click here for more BI Prime stories . 2020 … venture investors think could rock 2020 was government action. For Venrock partner Bryan Roberts, having the government do something material in healthcare would be the biggest surprise. That could be anything on healthcare costs or …

GSK

Salsify and The Scan Group Establish Partnership to Deliver Winning Digital Shelf Experiences for Global Brands | PR Newswire | 11/5/2019

… GSK, Rawlings, and Fruit of the Loom use Salsify every day to stand out on the digital shelf. To date, Salsify has raised a total of $98.1 million in funding, led by Greenspring Associates, Underscore VC, Venrock, Matrix Partners, and North Bridge. For more information, please visit https://www.salsify.com . About The Scan Group, Inc. The Scan Group is a dynamic, full-service marketing, design, technology, and print management group that …

Cerner

AI voice tech startup Suki partners with Google Cloud – Healthcare Dive | 10/31/2019

… workday on EHR and computer tasks. The startup was founded by Soni and is backed by funding from investors like Venrock, First Round and Social Capital. The company recently raised $20 million to advance the … with many EHR systems, including athenahealth’s Marketplace, Epic AppOrchard and Cerner, and plans to add more in the future. Share this …

Genentech

Top 10 San Francisco Bay Area Biotechs by Venture Capital Funding - BioSpace | 10/30/2019

… out of Illumina ’s startup accelerator, who was also one of the company’s investors, along with Arch Venture Partners and Venrock. The $104 million raise in June 2019 brought the company’s total funding to $158 … and dose-expansion trial of RMC-4530 in combination with Genentech ’s Cotellic (cobimetinib) in relapsed/refractory solid tumors with specific genomic mutations. RMC-4630 is a SHP2 inhibitor. Cotellic is a MEK inhibitor. 8 …

OrbiMed

Term Sheet: Oct. 16, 2019 | 10/16/2019

… the round. - Mable , a Boston-based startup mobile and web-based B2B wholesale platform, raised $3.1 million in seed funding. Venrock, Accomplice, and Founder Collective led the round. - Hummingbird Technologies , a London-based tech platform … of $8.3 million in 2018 and loss of $29.9 million. OrbiMed (34.6% pre-offering), Quaker BioVentures (21.2%), and Pacira Pharmaceuticals (13.6%) back the firm. It plans to list on the Nasdaq as “TELA.” Read more …

Celgene

Cyteir Therapeutics scores $40.2 mln Series B | PE Hub | 10/15/2019

Cyteir Therapeutics scores $40.2 mln Series B October 15, 2019 By Iris Dorbian Lexington, Massachusetts-based Cyteir Therapeutics , a developer of next-generation synthetic lethal therapies for cancer, has secured $40.2 million in Series B funding. Novo Holdings led the round with participation from Venrock, DROIA Oncology Ventures, Osage University Partners, Lightstone Ventures and Celgene Corporation . As part of this closing, Dr. Karen Hong of Novo Ventures will join the …

Pfizer

WeWork Tries to Address Investor Concerns With Big Governance Changes: Term Sheet | Fortune | 9/13/2019

… has raised more than $332 million in total venture capital funding since its inception. Its largest outside backers include Fidelity, Venrock, NEA, and Pelion Ventures. The company was last valued at $3.2 billion in the … revenue and posted a loss of $17.8 million in 2018. Pfizer, Bain, OrbiMed , and Perceptive Life Sciences back the firm. It plans to list on the Nasdaq as “SWTX.” Read more . – Satsuma Pharmaceuticals , a South …

Novartis

Secretive Defense Tech Startup Anduril Reaches Unicorn Status: Term Sheet | Fortune | 9/12/2019

… industry of supply chain and logistics management. He and co-founder Andrea Aranguren have raised $10 million in funding from Venrock and Rucker Park. This is O’Kelley’s third startup. Before AppNexus, he sold his first … company, raised $40 million in funding. Investors include Versant Ventures, Novartis Venture Fund, Novo Ventures and Celgene . Financial terms weren’t disclosed. PRIVATE EQUITY DEALS – High Street Insurance Partners , which is backed by Huron Capital , acquired …

GlaxoSmithKline

Depressive Disorders Pipeline Review 2010-2019: 50% of Treated Patients do not Respond to the First Prescribed Antidepressant | PR Newswire | 6/27/2019

… Lilly Euthymics Bioscience Evotec FUJIFILM Cellular Dynamics Fabre-Kramer Pharmaceuticals Federated Investors Foundation Medical Partners GAIA GNT Pharma Gedeon Richter GlaxoSmithKline Google Ventures GrowthWorks Hercules Capital Highland Capital Partners Holmusk IBM Watson Health INVENT Pharmaceuticals … of Michigan University of Oxford University of Toronto VANDA Pharmaceuticals Venrock VistaGen Therapeutics Wellcome Trust WestRiver Group Worldwide Clinical Trials Yungjin Pharmaceuticals e-therapeutics myStrength For more information about this report visit https://www.researchandmarkets.com/r …

Theranos

How to avoid funding the next Theranos: Guidelines for healthcare VCs - Business Insider | 6/14/2019

Healthcare investing often has greater scientific complexity than standard tech venture capital. Theranos is a well-known example of a risky healthcare bet gone wrong, but some experts say other problematic startups are on the … is a vice president at the Silicon Valley venture firm Venrock Dan Estes is a partner at Frazier Healthcare Partners John Ioannidis is a professor of medicine at Stanford who was an early Theranos whistleblower …

Amazon Web Services

CORRECTING and REPLACING VeloCloud Expands Integration of Cloud-Delivered SD-WAN to Amazon Web Services | Business Wire | 12/12/2017

… the following corrected version due a revision. The corrected release reads: VELOCLOUD EXPANDS INTEGRATION OF CLOUD-DELIVERED SD-WAN TO AMAZON WEB SERVICES AWS and VeloCloud Collaborate for Seamless Addition of SD-WAN to AWS … services delivery. VeloCloud has received financing from investors including NEA, Venrock, March Capital Partners, Hermes Growth Partners, Telstra Ventures, Khazanah Nasional Berhad, Cisco Investments, and The Fabric, and is headquartered in Mountain View, Calif. For …

Verily Life Sciences

Vice President Joe Biden to Keynote 6th Annual StartUp Health Festival | PRWeb | 12/7/2017

Venrock Clifton Leaf, Editor-in-Chief, Fortune Philip Marshall, Co-Founder & Chief Product Officer, Conversa Jessica Mega, MD, MPH, Chief Medical Officer, Verily Life Sciences Reed Mollins, Co-Founder & SVP, Business Development, Doctor.com Sachin Nanavati, Client Partner, Facebook Ameet Nathwani, M.D., EVP, Chief Medical Officer, Sanofi Bryan Roberts, PhD, Partner, Venrock Jim Lecinski, VP of U.S. Sales, Google Jerry Levin, Executive Chairman, StartUp Health Dean Ornish, MD, President & Founder, Preventive …

Rock Health

Venture capital and health system investors are bullish on tech startups | Modern Healthcare | 1/18/2020

… raised $39.5 billion since 2011, with 40% of that raised in 2018 and 2019 alone, according to a report from Rock Health , an early-stage digital health venture fund that also compiles research on the … problems, said Dr. Bob Kocher, partner at venture-capital firm Venrock and a former special assistant to the president for healthcare and economic policy during the Obama administration. When a startup proves its model is …

Lux Capital

What Casper’s IPO Prospectus Tells Us About Its Business | Fortune | 1/13/2020

… told The New York Times. “All of us said, ‘It’s not right.’” Josh Wolfe, co-founder of venture capital firm Lux Capital, spoke out on Twitter about the situation. He said this may be the … Byron Ling to partner, and Hootan Rashidifard to principal. \n– Venrock promoted Racquel Bracken and Ethan Batraski to partner and named Todd Graham as a vice president. \n– Levine Leichtman Capital Partners named Andrew Schwartz …

Silicon Valley Bank

Diabetes care platform Virta scores $93M | MobiHealthNews | 1/13/2020

The new funding was led by Caffeinated Capital with participation from Venrock, Obvious Ventures, Creandum, Playground Global and SciFi VC. Type 2 diabetes management company Virta announced a whopping $93 million Series C financing round … is hot in digital health. In fact, according to the Silicon Valley Bank , in 2018 diabetes companies raised $148 million — making it one of the most well-funded sectors of digital health. One of Virta’s …

Versant Ventures

Synthetic Lethality-based Drugs & Targets World Market, Forecast to 2030 by Type of Molecules, Different Target Indications, Synlet Targets, Route of Administration, and Key Geographical Regions | Globe Newswire | 1/9/2020

Venrock Versant Ventures Vivo Capital of Palo Alto Voyager Therapeutics Wellcome Sanger Institute Woodford Patient Capital Trust Worldwide Cancer Research WuXi AppTec Ventures WuXi Healthcare Ventures Yale School of Medicine Yale University Yunfeng Capital For more information about this report visit https://www.researchandmarkets.com/r/ms38j5 Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T …

8VC

Synthetic Lethality-based Drugs & Targets World Market, Forecast to 2030 by Type of Molecules, Different Target Indications, Synlet Targets, Route of Administration, and Key Geographical Regions | Globe Newswire | 1/9/2020

… 17 APPENDIX 1: TABULATED DATA 18 APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS 3W Partners 5AM Ventures 6 Dimensions Capital 8VC Abbott AbbVie AbbVie Ventures Abingworth Adage Capital Partners Adams Street Partners Advanced Technology Ventures … Services UT Southwestern Medical Center UTokyo Innovation Platform Vanderbilt University Venrock Versant Ventures Vivo Capital of Palo Alto Voyager Therapeutics Wellcome Sanger Institute Woodford Patient Capital Trust Worldwide Cancer Research WuXi AppTec Ventures WuXi Healthcare …

MPM Capital

Synthetic Lethality-based Drugs & Targets World Market, Forecast to 2030 by Type of Molecules, Different Target Indications, Synlet Targets, Route of Administration, and Key Geographical Regions | Globe Newswire | 1/9/2020

… Singapore Mission Bay Capital Mission Therapeutics Mitsubishi UFJ Capital Mizuho Capital Moffitt Cancer Center Morgan Noble Morgenthaler Ventures Morphic Therapeutics MPM Capital MS Ventures Mylan Myriad Genetics National Agency for Science and Technology National Cancer … Services UT Southwestern Medical Center UTokyo Innovation Platform Vanderbilt University Venrock Versant Ventures Vivo Capital of Palo Alto Voyager Therapeutics Wellcome Sanger Institute Woodford Patient Capital Trust Worldwide Cancer Research WuXi AppTec Ventures WuXi Healthcare …

Lightspeed Venture Partners

I’m a Millennial, and I Don’t Understand What Quibi Is Trying to Do | Fortune | 1/9/2020

… round, and was joined by investors including Citi Ventures, Fort Ross Ventures, 7 Global Capital , Khosla Ventures, Bain Capital Ventures, Lightspeed Venture Partners and Canvas Ventures. \n– Komodo Health , a healthcare data platform, raised $50 … for health systems, raised $42 million in Series D funding. Venrock and Highland Capital Partners co-led the round, and was joined by investors including Providence Ventures and Salesforce Ventures. \n– Soul Machines , a New …

ARCH Venture Partners

Synthetic Lethality-based Drugs & Targets World Market, Forecast to 2030 by Type of Molecules, Different Target Indications, Synlet Targets, Route of Administration, and Key Geographical Regions | Globe Newswire | 1/9/2020

… Cancer Research Amherst Fund Amoy Diagnostics Andera Partners Angel Investors Apexian Pharmaceuticals Apjohn Ventures Fund Apollo Munich Health Aptose Biosciences ARCH Venture Partners Arix Bioscience Arkin Holdings Artios Pharma Astellas Ventures AstraZeneca AtlasMedx Atrin Pharmaceuticals … Services UT Southwestern Medical Center UTokyo Innovation Platform Vanderbilt University Venrock Versant Ventures Vivo Capital of Palo Alto Voyager Therapeutics Wellcome Sanger Institute Woodford Patient Capital Trust Worldwide Cancer Research WuXi AppTec Ventures WuXi Healthcare …

Vulcan Capital

The top 21 startups to watch that are disrupting the energy industry - Business Insider | 1/9/2020

… 289 million, according to a company spokesperson Funding: $189 million Largest deal: $71 million; February 1, 2017 Notable investors: UBS; Venrock Capital; and Oak Investment Partners LanzaTech — $418 million Illinois-based LanzaTech uses bioreactors filled … 20, 2016 Notable investors: Google’s parent company, Alphabet; Goldman Sachs; Vulcan Capital; and Italian energy giant Enel …

Andreessen Horowitz

The top tech trends of 2020, from AI to 5G | 12/23/2019

… talking in 2020 and beyond. Their statements have been lightly edited for clarity. Healthcare and science Vijay Pande, general partner, Andreessen Horowitz: AI has the potential to democratize healthcare. With a natural place in virtually … some of the toughest to cure. advertisement Bryan Roberts, partner, Venrock: Inscripta’s automated desktop gene editor, Onyx takes a single/low multiplex, laborious manual process of CRISPR gene editing to a highly multiplexed, automated, industrially …

Sutter Hill Ventures

The Weekly Notable Startup Funding Report: 12/23/19 | 12/22/2019

… in total equity funding and is backed by investors that include Cantos, City Light Capital, Industry Ventures, Stanford University, and Venrock. HqO $34.3M - Series B Boston-based HqO develops a tenant experience platform for the … that include ARCH Venture Partners, Bill Gates, Sequoia Capital China, Sutter Hill Ventures, and WuXi NextCODE. Gecko Robotics $40.0M - Series B Pittsburgh-based Gecko Robotics develops and operates robots to perform infrastructure inspections by climbing …

Founders Fund

The Weekly Notable Startup Funding Report: 12/23/19 | 12/22/2019

… in total equity funding and is backed by investors that include Cantos, City Light Capital, Industry Ventures, Stanford University, and Venrock. HqO $34.3M - Series B Boston-based HqO develops a tenant experience platform for the … total equity funding and is backed by investors that include Founders Fund, FundersClub, Louis Beryl, Mark Cuban, and Y Combinator. Osano $5.4M - Series A Austin-based Osano is an easy-to-use data privacy platform …

Industry Ventures

The Weekly Notable Startup Funding Report: 12/23/19 | 12/22/2019

… Industry Ventures, Stanford University, and Venrock. HqO $34.3M - Series B Boston-based HqO develops a tenant experience platform for the commercial real estate. Founded by Chase Garbarino, Greg Gomer, Jared Stenquist, and Kevin Mccarthy in 2018, HqO has now raised a total of $46.9M in total equity funding and is backed by investors that include Accomplice, Insight Partners, MetaProp NYC, Navitas Capital, and Pritzker Group Venture Capital. Evisort $15.0M - Series …

GGV Capital

The Weekly Notable Startup Funding Report: 12/23/19 | 12/22/2019

… 2016, Domio has now raised a total of $166.0M in total equity funding and is backed by investors that include GGV Capital, SoftBank, Tenaya Capital, Tribeca Venture Partners, and Upper90. Jumpstart $8.5M - Series A San … include Cantos, City Light Capital, Industry Ventures, Stanford University, and Venrock. HqO $34.3M - Series B Boston-based HqO develops a tenant experience platform for the commercial real estate. Founded by Chase Garbarino, Greg Gomer, Jared …

Foundry Group

Misty Robotics Launches .NET SDK for the Misty II Robot | 12/3/2019

… Venrock, Foundry Group and others. View source version on businesswire.com: https://www.businesswire.com/news/home/20191203005322/en/ Published December 3, 2019 Copyright © 2019 SYS-CON Media, Inc. — All Rights Reserved. Syndicated stories and blog feeds, all rights reserved by the author …

New Enterprise Associates

Stride Analysis Reveals Nearly 1 in 4 Gig Workers Pay Less Than $1 Per Month For Qualified Health Insurance Plans | PR Newswire | 11/21/2019

… Venrock, New Enterprise Associates and F-Prime Capital Partners. For more information, visit www.stridehealth.com . SOURCE Stride Related Links http://www.stridehealth.com …

F-Prime Capital

Stride Analysis Reveals Nearly 1 in 4 Gig Workers Pay Less Than $1 Per Month For Qualified Health Insurance Plans | PR Newswire | 11/21/2019

… Venrock, New Enterprise Associates and F-Prime Capital Partners. For more information, visit www.stridehealth.com . SOURCE Stride Related Links http://www.stridehealth.com …

Spark Capital

CB Insights - Digital Health 150: The Digital Health Startups Redefining The Healthcare Industry | 11/14/2019

… investors among the companies selected. Investor Number of deals F-Prime Capital 31 New Enterprise Associates 30 Google Ventures 29 Venrock 28 Founders Fund 27 Khosla Ventures 27 GE Ventures 22 Social Capital 20 .406 … total disclosed funding from investors including Compound, Norwest Venture Partners, Spark Capital, and SoftBank, among others. Other companies in this category use remote monitoring technology to supplement virtual care services. Table of the Digital Health …

Goldman Sachs

CB Insights - Digital Health 150: The Digital Health Startups Redefining The Healthcare Industry | 11/14/2019

… investors among the companies selected. Investor Number of deals F-Prime Capital 31 New Enterprise Associates 30 Google Ventures 29 Venrock 28 Founders Fund 27 Khosla Ventures 27 GE Ventures 22 Social Capital 20 .406 … startup raised a $50M Series C in October 2018 from Goldman Sachs and Frazier Healthcare Partners. Another example is Talkspace , which offers psychotherapy services delivered virtually. It has raised $109M in total disclosed funding from …

Sequoia Capital

CB Insights - Digital Health 150: The Digital Health Startups Redefining The Healthcare Industry | 11/14/2019

… investors among the companies selected. Investor Number of deals F-Prime Capital 31 New Enterprise Associates 30 Google Ventures 29 Venrock 28 Founders Fund 27 Khosla Ventures 27 GE Ventures 22 Social Capital 20 .406 … Series B round in September 2018 with participating investors including Sequoia Capital and Oak HC/FT Partners, among others. Senior care The growing size of the aging population is creating an increased demand for tech …

Norwest Venture Partners

CB Insights - Digital Health 150: The Digital Health Startups Redefining The Healthcare Industry | 11/14/2019

… investors among the companies selected. Investor Number of deals F-Prime Capital 31 New Enterprise Associates 30 Google Ventures 29 Venrock 28 Founders Fund 27 Khosla Ventures 27 GE Ventures 22 Social Capital 20 .406 … raised $109M in total disclosed funding from investors including Compound, Norwest Venture Partners, Spark Capital, and SoftBank, among others. Other companies in this category use remote monitoring technology to supplement virtual care services. Table of …

Google Ventures

CB Insights - Digital Health 150: The Digital Health Startups Redefining The Healthcare Industry | 11/14/2019

Google Ventures 29 Venrock 28 Founders Fund 27 Khosla Ventures 27 GE Ventures 22 Social Capital 20 .406 Ventures 19 Andreessen Horowitz 18 Track all the Digital Health 150 Startups in this brief and many more on our platform The 150 private digital health startups working to recreate how healthcare is delivered. Look for The Digital Health 150 in the Collections tab. Digital Health 150 150 items CLONE Collections is …

Social Capital

CB Insights - Digital Health 150: The Digital Health Startups Redefining The Healthcare Industry | 11/14/2019

Venrock 28 Founders Fund 27 Khosla Ventures 27 GE Ventures 22 Social Capital 20 .406 Ventures 19 Andreessen Horowitz 18 Track all the Digital Health 150 Startups in this brief and many more on our platform The 150 private digital health startups working to recreate how healthcare is delivered. Look for The Digital Health 150 in the Collections tab. Digital Health 150 150 items CLONE Collections is the first collaborative …

Bain Capital Ventures

Nightfall AI Gets Funded to Secure Cloud Data – Tehrani.com – Comm & Tech Blog | 11/11/2019

November 11, 2019 Nightfall AI Gets Funded to Secure Cloud Data As chat clouds like Slack and programming clouds like Github continue to grow, a huge challenge facing corporations is important information from leaking out. The same challenge exists for all cloud workloads in fact. To help solve this problem, Nightfall AI (formerly known as Watchtower AI), launched with $20.3 million in funding led by Bain Capital Ventures and Venrock

Bain Capital

Nightfall AI Gets Funded to Secure Cloud Data – Tehrani.com – Comm & Tech Blog | 11/11/2019

November 11, 2019 Nightfall AI Gets Funded to Secure Cloud Data As chat clouds like Slack and programming clouds like Github continue to grow, a huge challenge facing corporations is important information from leaking out. The same challenge exists for all cloud workloads in fact. To help solve this problem, Nightfall AI (formerly known as Watchtower AI), launched with $20.3 million in funding led by Bain Capital Ventures and Venrock

Kaiser Permanente

Venture capital and health system investors are bullish on tech startups | Modern Healthcare | 1/18/2020

… from an investment perspective: HealthCatalyst The data warehousing and analytics company’s share price rose 33% in 2019 after its IPO. Kaiser Permanente Ventures and the UPMC health system were among the company’s initial investors. Livongo … problems, said Dr. Bob Kocher, partner at venture-capital firm Venrock and a former special assistant to the president for healthcare and economic policy during the Obama administration. When a startup proves its model is …

The downside of strong growth in health care jobs: higher costs - STAT | 1/14/2020

… 10 employers are health care systems. Even in the Bay Area , health care systems are among the top employers, with Kaiser Permanente and Sutter Health employing more people than Google. This is a problem because … Affairs, June 2020). Bob Kocher, M.D., is a partner at Venrock, a venture-capital firm; a nonresident senior fellow at the University of Southern California’s Schaeffer Center for Health Policy and Economics; and an adjunct …

HCA

Iris Dorbian wrote a new post, Oxford Finance provides $60 mln to VC-backed RefleXion Medical, on the site PE Hub | 5/1/2019

Oxford Finance provides $60 mln to VC-backed RefleXion Medical May 1, 2019 Print Email Oxford Finance LLC has provided a $60 million loan to Hayward, California-based RefleXion Medical Inc , a biotargeting oncology company. Armentum Partners served as financial adviser to RefleXion Medical on the financing. RefleXion is backed by TPG Growth/The Rise Fund, Sofinnova Partners, KCK Group, Venrock, T. Rowe Price Associates, Inc, GT Healthcare Capital Partners …

75% of healthcare experts struggle with implementing blockchain | Becker’s Hospital Review | 4/18/2019

75% of healthcare experts struggle with implementing blockchain Mackenzie Garrity - Print Email Venrock released its 2019 Healthcare Prognosis report, which included insights on the progress of artificial intelligence and blockchain within the industry. In 2019, blockchain in healthcare may not exist, Venrock found. The report showed that 75 percent of industry experts are struggling to find blockchain’s role in healthcare. Another 18 percent are finding use cases that benefit patients …

Humana

Health insurers and retail pharmacies are making a play for primary care | MSN | 12/26/2019

… retail pharmacies are making a play for primary care MarketWatch 1 hr ago Jaimy Lee A handful of companies like Humana Inc. and Walgreens Boots Alliance Inc. that are better known for operating pharmacy counters … said Dr. Bob Kocher, a partner at venture-capital firm Venrock. “There is a belief that the pendulum is swinging to the next-generation version of managed care.” : Expect stock volatility for some health care …

Health insurers and retail pharmacies are making a play for primary care - MarketWatch | 12/24/2019

A handful of companies like Humana Inc. and Walgreens Boots Alliance Inc. that are better known for operating pharmacy counters and managing health plans are now turning into primary care providers. CVS Health Corp. CVS … said Dr. Bob Kocher, a partner at venture-capital firm Venrock. “There is a belief that the pendulum is swinging to the next-generation version of managed care.” Read: Expect stock volatility for some health …

Oscar Health

10 top VCs share their best 2020 healthcare predictions, from a booming IPO market to pharma companies getting into the medical care business | Business Insider | 12/19/2019

… get access to all exclusive Business Insider PRIME content. We asked healthcare and biotech venture capitalists from leading firms like Venrock, Andreessen Horowitz, and Lux Capital to share their predictions for 2020. They shared where … Medicare Advantage market growing. GV is an investor in both Oscar Health and Clover Health, which offer Medicare Advantage plans. As politicians and policy experts think through what a “Medicare for All” plan might look …

CB Insights - Digital Health 150: The Digital Health Startups Redefining The Healthcare Industry | 11/14/2019

… UK. 2019 Digital Health 150 Unicorn Startups Company Category Country We Doctor Providers: Primary Care China GRAIL Genomics United States Oscar Health Insurance & Benefits United States Tempus Drug R&D: Real-World Evidence United States … Prime Capital 31 New Enterprise Associates 30 Google Ventures 29 Venrock 28 Founders Fund 27 Khosla Ventures 27 GE Ventures 22 Social Capital 20 .406 Ventures 19 Andreessen Horowitz 18 Track all the Digital Health …

Clover Health

10 top VCs share their best 2020 healthcare predictions, from a booming IPO market to pharma companies getting into the medical care business | Business Insider | 12/19/2019

… get access to all exclusive Business Insider PRIME content. We asked healthcare and biotech venture capitalists from leading firms like Venrock, Andreessen Horowitz, and Lux Capital to share their predictions for 2020. They shared where … seniors 65 and older. That’s in part because startups like Clover Health and Bright Health have started operating for enough years outside their core markets of New Jersey and Colorado, respectively, for investors to start …

The mad rush to sell private Medicare plans to seniors | 10/11/2019

… this year for WellCare Health Plans Inc. in part to get access to the company’s large Medicare business. Startups like Clover Health, which has raised more than $900 million from investors including GV, Alphabet Inc … 20 years,” said Bob Kocher, a partner at venture firm Venrock. The firm backed Devoted Health and Kocher served as the company’s chief medical officer for a year. “There should be a lot of pent …

Scott Gottlieb

** | 1/12/2020**

… air. “It’s a mixed bag,” he said. Experts such as Dr. Bob Kocher, a partner at the venture capital firm Venrock, are blunter. “Most AI products have little evidence to support them,” Kocher said. Some … than makers of traditional devices, such as X-ray machines. Scott Gottlieb said in 2017 while he was FDA commissioner that government regulators need to make sure its approach to innovative products “is efficient and …

Patty Murray

** | 1/12/2020**

… air. “It’s a mixed bag,” he said. Experts such as Dr. Bob Kocher, a partner at the venture capital firm Venrock, are blunter. “Most AI products have little evidence to support them,” Kocher said. Some … Sens. Elizabeth Warren (D-Mass.), Tina Smith (D-Minn.) and Patty Murray (D-Wash.) questioned the agency’s ability to ensure company safety reports are “accurate, timely and based on all available information.” When Good Algorithms …

Bakul Patel

** | 1/12/2020**

… air. “It’s a mixed bag,” he said. Experts such as Dr. Bob Kocher, a partner at the venture capital firm Venrock, are blunter. “Most AI products have little evidence to support them,” Kocher said. Some … results will not change after they enter the market, said Bakul Patel, director for digital health at the FDA’s Center for Devices and Radiological Health. The FDA has not yet authorized “unlocked” AI devices, whose …

Tina Smith

** | 1/12/2020**

… air. “It’s a mixed bag,” he said. Experts such as Dr. Bob Kocher, a partner at the venture capital firm Venrock, are blunter. “Most AI products have little evidence to support them,” Kocher said. Some … October letter to the FDA, Sens. Elizabeth Warren (D-Mass.), Tina Smith (D-Minn.) and Patty Murray (D-Wash.) questioned the agency’s ability to ensure company safety reports are “accurate, timely and based on all …

Allen Hamilton

** | 1/12/2020**

… air. “It’s a mixed bag,” he said. Experts such as Dr. Bob Kocher, a partner at the venture capital firm Venrock, are blunter. “Most AI products have little evidence to support them,” Kocher said. Some … peer-reviewed journal,” said Joachim Roski, a principal at Booz Allen Hamilton, a technology consulting firm, and co-author of the National Academy’s report. “That’s not how the U.S. economy works.” But Oren Etzioni, chief …

Donald Trump

Samsung just took the wraps off a gorgeous new super-thin 8K TV, and the front is almost entirely screen | 1/7/2020

… best 2020 healthcare predictions, from a booming IPO market to pharma companies getting into the medical care business VCs from Venrock, Andreessen Horowitz, and Lux Capital are placing bets on new ways of going to … awaiting trial on sex trafficking charges. Jeffrey Epstein once counted Donald Trump and Bill Clinton in his social circle, among other celebrity friends. Read More » There’s a $1,000 price difference for a room in the …

Adam Neumann

A stock picker in Wall Street’s top 1% tells us how he thrived with ‘companies you wouldn’t find on your own’ — and shares the top 4 investing themes he’s playing in 2020 | 12/21/2019

… healthcare predictions, from a booming IPO market to pharma companies getting into the medical care business Lydia Ramsey VCs from Venrock, Andreessen Horowitz, and Lux Capital are placing bets on new ways of going to … buying more fast-food chains. Read More » The last interview Adam Neumann gave as CEO of WeWork details the now-controversial working relationship with Softbank CEO Masayoshi Son Richard Feloni,Alyson Shontell WeWork cofounder Adam …

Iris Dorbian

Cyteir Therapeutics scores $40.2 mln Series B | PE Hub | 10/15/2019

Cyteir Therapeutics scores $40.2 mln Series B October 15, 2019 By Iris Dorbian Lexington, Massachusetts-based Cyteir Therapeutics , a developer of next-generation synthetic lethal therapies for cancer, has secured $40.2 million in Series B funding. Novo Holdings led the round with participation from Venrock, DROIA Oncology Ventures, Osage University Partners, Lightstone Ventures and Celgene Corporation . As part of this closing, Dr. Karen Hong of Novo Ventures will join the …

Chris Dixon

Exclusive: From CryptoKitties to Cardi B: Warner Music Joins $11 Million Investment In Ethereum Replacement | Forbes | 9/12/2019

… company’s roster of superstar talent. So as part of the investment from Andreessen Horowitz, Digital Currency Group, Union Square Ventures, Venrock and others, Bronikowski says Warner Music’s blockchain team will work with Dapper Labs to … receives approval from the Securities & Exchange Commission (SEC). Existing investors Chris Dixon of Andreessen Horowitz, Fred Wilson of Union Square Ventures and David Pakman of Venrock are already on Dapper’s board, and no other seats …

Fred Wilson

Exclusive: From CryptoKitties to Cardi B: Warner Music Joins $11 Million Investment In Ethereum Replacement | Forbes | 9/12/2019

… company’s roster of superstar talent. So as part of the investment from Andreessen Horowitz, Digital Currency Group, Union Square Ventures, Venrock and others, Bronikowski says Warner Music’s blockchain team will work with Dapper Labs to … Exchange Commission (SEC). Existing investors Chris Dixon of Andreessen Horowitz, Fred Wilson of Union Square Ventures and David Pakman of Venrock are already on Dapper’s board, and no other seats are being created as part …

Ed Sheeran

Exclusive: From CryptoKitties to Cardi B: Warner Music Joins $11 Million Investment In Ethereum Replacement | Forbes | 9/12/2019

… Warner Music Group has mastered streaming, generating $2 billion in revenue from the technology, the music giant behind Cardi B, Ed Sheeran and Bruno Mars has set its sights on blockchain, joining an $11.2 million … investment from Andreessen Horowitz, Digital Currency Group, Union Square Ventures, Venrock and others, Bronikowski says Warner Music’s blockchain team will work with Dapper Labs to create digital assets using a new public blockchain revealed today …

Bruno Mars

Exclusive: From CryptoKitties to Cardi B: Warner Music Joins $11 Million Investment In Ethereum Replacement | Forbes | 9/12/2019

… has mastered streaming, generating $2 billion in revenue from the technology, the music giant behind Cardi B, Ed Sheeran and Bruno Mars has set its sights on blockchain, joining an $11.2 million investment in Dapper … investment from Andreessen Horowitz, Digital Currency Group, Union Square Ventures, Venrock and others, Bronikowski says Warner Music’s blockchain team will work with Dapper Labs to create digital assets using a new public blockchain revealed today …

David Pakman

Exclusive: From CryptoKitties to Cardi B: Warner Music Joins $11 Million Investment In Ethereum Replacement | Forbes | 9/12/2019

… company’s roster of superstar talent. So as part of the investment from Andreessen Horowitz, Digital Currency Group, Union Square Ventures, Venrock and others, Bronikowski says Warner Music’s blockchain team will work with Dapper Labs to … of Andreessen Horowitz, Fred Wilson of Union Square Ventures and David Pakman of Venrock are already on Dapper’s board, and no other seats are being created as part of the investment. While contributed less than …

Matthew Prince

Cloudflare sets price range for IPO of $10 to $12 per share - Business Insider | 9/3/2019

Cloudflare cofounders, CEO Matthew Prince and COO Michelle Zatlyn Anthony Harvey/Getty Images San Francisco security startup Cloudflare , on Tuesday set a price range for its IPO of $10 to $12 per share. At the … private capital. Its biggest shareholders include its Series A backers Venrock and Pelion Ventures, as well as its Series B lead, New Enterprise Associates. But its biggest shareholder of all is Fidelity, which led a …

Matt Eakins

Leading Women’s Health Care Company Partners with Suki to Offer Digital Voice Assistant for its Physicians | PR Newswire | 6/11/2019

… incredibly personal, and Suki helps providers to concentrate on providing exceptional care by lowering the barrier created by EHRs,” said Matt Eakins , MD, Chief Operating Officer at Unified. “Suki not only helps our providers more … Redwood City, Calif. , Suki is backed by investors such as Venrock, First Round, Social Capital, and Marc Benioff . To learn more, visit suki.ai , or follow them on AngelList , Facebook , LinkedIn , and Twitter . About Unified Physician …

Kirk Falconer

Kirk Falconer wrote a new post, Venture-backed Milestone prices Nasdaq IPO to raise $111 mln, on the site PE Hub | 5/9/2019

… 105 million raised last year , led by RTW Investments and joined by BDC Capital , Domain Associates , Fonds de solidarité FTQ , Forbion , GO Capital , Novo Holdings , Pappas Capital , Tavistock Group , Tekla Capital Management and Venrock . PRESS RELEASE Milestone Pharmaceuticals Announces Pricing of Upsized Initial Public Offering MONTREAL and CHARLOTTE, N.C., May 8, 2019 /CNW/ — Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a Phase 3 clinical-stage biopharmaceutical company dedicated to developing and commercializing …

Christopher A. Herr

Oxford Finance Closes $60 Million Credit Facility with Oncology Innovator RefleXion Medical | PR Newswire | 5/1/2019

… and in the same session, while minimizing the impact on healthy tissue surrounding each tumor, has not been available,” said Christopher A. Herr , senior managing director at Oxford. “RefleXion’s biology-guided radiotherapy is designed to … firms TPG Growth/The Rise Fund, Sofinnova Partners, KCK Group, Venrock, T. Rowe Price Associates, Inc., China -focused healthcare investment firm GT Healthcare Capital Partners, and global pharmaceutical leaders Pfizer Venture Investments and Johnson & Johnson …

Joseph Oliveto

IPO Update: Milestone Pharmaceuticals Readies $75 Million IPO - Milestone Pharmaceuticals (Pending:MIST) | Seeking Alpha | 5/1/2019

… cardiovascular diseases, including paroxysmal supraventricular tachycardia episodes (PSVT), atrial fibrillation, and angina. Management is headed by CEO, President, and Director Joseph Oliveto , who has been with the firm since 2016 and was previously CEO at … Forbion Capital Partners, Boxer Capital, Domain Associates, GO Capital, and Venrock Healthcare Partners, among others. Source: VentureDeal Venture Capital Database Market & Competition According to a 2019 market research report by Market Research Future, the global …

David Thrower

Biolux Research Raises $14M in Series A Round led by Venrock; Appoints David Thrower as Chief Executive Officer | 4/30/2019

30/04/2019 Biolux Research announced the close of a $14M Series A round led by Venrock and joined by Correlation Ventures, insiders and other investors. Coincident with the completion of the round, Biolux announced that David Thrower has been appointed Chief Executive Officer of the company. Biolux manufactures OrthoPulse, an FDA cleared orthodontic device currently being sold in the United States, Europe, and Asia. OrthoPulse is a non-invasive technology which …

Joe Biden

HITAC wrestles with foundational questions - POLITICO | 4/26/2019

… against the e-prescription giant portends more trouble for tech companies. — Biden bows out of Cancer Initiative: Former Vice President Joe Biden joined the 2020 presidential race and resigned as co-chair of the nonprofit … I am feeling happy that [S]urescripts is getting scrutiny,” Venrock venture capitalist Bob Kocher says. One industry executive wondered if FTC might next go after the “EHR duopoly”: Epic and Cerner. But Doug Litvack …

Seema Verma

Venrock report: Health tech players see Apple Watch as a clinical tool, “Medicare-for-all” as opportunity for growth | MobiHealthNews | 4/17/2019

Search form Search Venrock report: Health tech players see Apple Watch as a clinical tool, ‘Medicare-for-all’ as opportunity for growth The report surveyed 250 industry players including health IT startups, large employers, insurance … a focal point of that conversation. Last week, CMS Administrator Seema Verma warned against government run healthcare programs, saying they would hinder innovation. “One of the things that troubles me in terms of how we …

Jason Zintak

6sense raises $27 million for its marketing and sales predictive analytics tool | VentureBeat | 4/16/2019

Venrock also participating. 6sense, which described the new round as “growth funding following series B,” has raised $63 million to date. 6sense CEO Jason Zintak said the five-year-old startup, which last year doubled its headcount and expanded its offices in New York and India, will use the fresh capital to expand its product offering and acquire new clients. “The funding will allow 6sense to expand its product, including …

Ken Wallace

6sense Secures $27 Million to Advance Bold Vision in B2B and ABM | Business Wire | 4/16/2019

… led by Industry Ventures and included participation from existing investors Bain Capital Ventures , Battery Ventures , Costanoa Ventures , Salesforce Ventures , and Venrock . “We believe AI insights and orchestration are the future of B2B sales and marketing … sales teams need to identify and close new business,” said Ken Wallace of Industry Ventures, a leading investment firm with over $3.4 billion of institutional capital. “We believe 6sense’s unmatched ability to uncover previously unknown …

Raj Prabhu

After record-setting 2018, digital health venture funding levels off | FierceHealthcare | 4/16/2019

… down compared to last year in digital health in the absence of larger deals. M&A activity was also flat,” Raj Prabhu, CEO of Mercom Capital Group, said in a statement. “However, digital health public … nearing a bubble as an over-capitalized market. A recent Venrock report based on a survey of healthcare professionals found strong enthusiasm for health IT companies, with 78% of survey respondents predicting the number of …

Bob Kocher

Practice Fusion acquired by Allscripts for $100 million in cash | CNBC | 1/8/2018

… Bob Kocher, a health and technology investor at Venture firm Venrock, which did not invest in Practice Fusion. “A company with so much promise has fallen so far.” Practice Fusion last raised a big venture round in 2013 at a $700 million valuation. In January 2016, The New York Times reported that the company had hired JPMorgan to explore an IPO that could value Practice Fusion at $1.5 billion, on …